Liverpool Big Data Collaboration

C/O Royal Liverpool & Broadgreen University Hospitals Trust

Prescot Street

Liverpool

L7 8XP

Details

Quick Actions

Collaboration partners

Site Links

Partner login Stay in touch

Use-Cases: Big Data Applied

You are here: home > use-cases

Big data can be applied in different ways in different situations spanning operations, clinical and research environments.

For operational and clinical use it is through “use-cases” that the benefit of big data can be realised. It is also at this level that the full context can be considered enabling the operating model changes to be understood alongside the anticipated benefit and required investment. In parallel research use of big data enables hitherto hidden insights to be derived through the available data sets and applied analytics capability.

LBDC has developed a comprehensive use-case methodology from initial concepts through to post deployment benefits realisation management, alongside a clear research benefit model as set out below.

Use-cases are the specific scaled applications of big data which deliver value …

Use-cases are delivered through robust, scalable algorithms and analytic models which automate production of predictive analytics such that the insights can be used in close to real time with patients at the point the predictive insight is needed.

Whilst deployment of big data predictive analytics is the principal source of value realisation in operational scale, value can also be derived through realisation of new research opportunities enabled by enhanced data access and analytics capabilities.

As shown in the diagram to the left, the benefit of the LBDC programme can be seen in tiers from data access, through advanced analytics, to production scale (ie robust automated models and algorithms). Each build on the former and apply to different degrees based on the type of use involved.

For all use profiles a common theme is having unified and appropriately governed access to the collective data sets. Today accessing some of this data can be possible for research purposes through individual agreement at a point in time but via LBDC and allied programmes, access to full, real-time data sets opens new research opportunities.

The advanced big data analytics and associated data science capabilities open new capabilities for all applications, but this does not have to be only route. In some research situations researchers may wish to manipulate the data directly using other approaches.

Recognition of these differences and the common areas of benefit lie at the heart of the collaboration. The strategy has therefore been developed to cater for each of these aspects on an equitable basis.

For LBDC to be successful, use-cases must be successful.

To help ensure this is the case the LBDC strategy provides a clear effective, transparent and robust use case development and deployment methodology. From concept, through feasibility, to business case stages and beyond, the gated methodology ensures resources are directed to use cases with greatest merit. The gated portfolio approach also ensures full visibility to help ensure transparency for all involved.

To progress beyond business case stages, use-cases need to either cost justify (based on savings, revenue or capacity enhancement) or be sufficiently compelling to attract external clinical/research funding.

Where business cases are approved to move to implementation, further gated stages are involved with full portfolio management extending to full benefits realisation management.

The use-case methodology and wider strategy ensures that LBDC can effectively address multiple use-cases over time, each with their own business case and associated implementation/project plans.

To learn more please take a look at the LBDC Overview brochure or get in touch using the links opposite.

USE CASE METHODOLOGY

Ensuring successful realisation of operational and clinical use-cases.

Incubation of an initial portfolio of candidate (ie pre-business case stage) use-cases is a key theme of the LBDC phase 1 programme.

During this phase, a portfolio of six candidate use-cases are being developed to business case level. The process of evaluation, feasibility analysis and business case development in accordance with the gated portfolio approach will ensure the use-case taken to business case level are robust with compelling business cases.

Currently a use-case to reduce 30 Day Emergency Readmissions has been analysed to business case level with others currently at concept and feasibility stages.

Please revisit soon to learn more about the portfolio we are developing, or register for updates and we will keep you posted.

USE CASE PORTFOLIO DEVELOPMENT

Incubating a portfolio of high impact operational and clinical use cases

RESEARCH & ANALYTICS APPLICATIONS

Data, analytics and use-case value for all LBDC Partners

30 DAY EMERGENCY READMISSIONS

HEALTHCARE ACQUIRED INFECTIONS

An operational use-case which helps avoid emergency readmissions through effective risk profiling and intervention support.

A use case currently at concept level intended to identify those at greatest risk of HCAI based on multiple data sets such that effective interventions can be taken to reduce the risk.

Get in touch

Download the Overview

OPERATIONAL USE CASES

CLINICAL USE CASES

Applying predictive analytics to help avoid potentially preventable events such as HCAI and emergency readmissions

Applying predictive analytics to clinical practice primarily in chronic condition avoidance and management.

	Type of Use
Benefit tier	Operations	Clinical	Clinical Research	Pure Research
Use cases
Analytics
Data access

Get in touch

Download the Overview

To learn more please take a look at the LBDC Overview brochure or get in touch using the links below: